TG Therapeutics (TGTX) had the highest return in 2002 by a US stock in the Nasdaq Composite (IXIC), returning 281,150%.
| ASSET | YEAR | % RETURN |
|---|---|---|
TG Therapeutics (TGTX) | 2002 | 281,150.03% |
Thomson Reuters Corporation Common Shares (TRI) | 2002 | 17,685.91% |
Alto Ingredients (ALTO) | 2002 | 11,732.06% |
Live Ventures (LIVE) | 2002 | 6,761.43% |
Precipio (PRPO) | 2002 | 6,135.93% |
NetEase (NTES) | 2002 | 1,423.45% |
Xcel Brands (XELB) | 2002 | 600% |
Sohu (SOHU) | 2002 | 442.37% |
Marker Therapeutics (MRKR) | 2002 | 412.82% |
Royal Gold (RGLD) | 2002 | 390.55% |
Sleep Number (SNBR) | 2002 | 377.17% |
Yunhong Green CTI (YHGJ) | 2002 | 325.85% |
Encore Capital (ECPG) | 2002 | 323.08% |
Ziff Davis (ZD) | 2002 | 310.34% |
Simulations Plus (SLP) | 2002 | 182.38% |
Stonex (SNEX) | 2002 | 182.25% |
LivePerson (LPSN) | 2002 | 176.47% |
Capricor Therapeutics (CAPR) | 2002 | 174.51% |
Security National Financial (SNFCA) | 2002 | 172.63% |
PetMed Express (PETS) | 2002 | 153.42% |
Gentherm (THRM) | 2002 | 144.14% |
US Global Investors (GROW) | 2002 | 144.03% |
City (CHCO) | 2002 | 137.82% |
Central Garden & Pet (CENT) | 2002 | 137.31% |
Americas Car-Mart (CRMT) | 2002 | 136.11% |